The MV Hondius outbreak has renewed focus on hantavirus vaccines, with Moderna developing an mRNA-based shot. The Andes strain's high mortality rate underscores the urgency for effective solutions.
Hantavirus Vaccine: Moderna Has Been Developing a Vaccine Since 2023 in Collaboration with a Korean University
